Prescribing practices that increase risk of opioid overdose April 11, 2017 By Tracey Walker Two studies, one from Prime Therapeutics and Stanford, reveal an alarming increase in overdose with concurrent use of opioids and benzodiazepines. Here’s how managed care can help. More resources needed for medication-assisted treatment March 14, 2017 By Tracey Walker Include medication-assisted treatment high on the list of clinical tools used to treat opioid addiction. Four developments helping address the opioid epidemic October 04, 2016 By Aubrey Westgate As the opioid epidemic continues across the U.S., new treatment programs and guidelines could help reverse the trend. Top 4 ways US is combating opioid epidemic July 11, 2016 By Christine Blank Expanding access to buprenorphine, a medication to treat opioid use disorder, is one of several new actions announced by Health and Human Services (HHS) to combat the opioid epidemic. Here are the top 4 new provisions from HHS. Pharmacists should get training in naloxone use now Pharmacists are the most accessible healthcare resource. Once trained in naloxone use, we can train our patients in all aspects of opioid use. This will make a difference. HHS tackles opioid epidemic July 09, 2016 By Tracey Walker HHS is taking formal steps to address opioid addiction, a widely recognized national public health crisis. Find out the policy changes. Will price impede recently approved implant for opioid addicts? May 26, 2016 By Tracey Walker Probuphine implant could be a new option for addicts if obstacles, such as price, don’t get in the way. FDA panel greenlights Probuphine for opioid addiction January 14, 2016 By Erin Bastick FDA advisers recommended approval of the first long-acting, subdermal buprenorphine implant (Probuphine, Titan Pharmaceuticals, Inc. and Braeburn Pharmaceuticals) for the maintenance treatment of opioid addiction. Buccal buprenorphine approved for patients with chronic pain October 27, 2015 By Erin Bastick FDA has approved buprenorphine (Belbuca, Endo Pharmaceuticals) buccal film for use in patients with chronic pain. Opioid-dependent patients in ED need more than a treatment referral When addiction treatment was added to the buprenorphine Rx the result was greatly improved outcomes.